Who We Are?
Aqueduct Medical Ltd. Alleviates the discomfort and the potential complications to which millions of women each year are exposed when undergoing cervical dilation prior to intrauterine procedures.
Market & Unmet Need:
Approximately 3 million cervical dilations are performed annually in the United States for the purpose of intra-uterine procedures including: abortions, hysteroscopies, and other dilation & curettages. Cervical dilation allows medical practitioners greater access to the inside of the uterus in order to insert surgical tools for the completion of intra-uterine procedures.
Until now, there have been primarily two techniques for dilating the cervix. The first technique is the insertion of laminaria (dry, sterile seaweed) into the cervix. When laminaria comes into contact with body fluids, it expands and enlarges the opening of the cervix. Often, this process requires two patient visits and approximately 10-12 hours for sufficient dilation to occur. The second technique, referred to as Hegar dilation, involves the insertion and removal of metal rods that are graduated in increasing diameter. This process is painful, requiring the use of anesthesia, and is associated with a risk of uterine and cervix damage (cervical incompetence). Read More...
Meet Our Team
CHAIRMAN OF THE BOARD:
Zohar Gendler M.Sc., M.B.A, CEO of the NGT technological Incubator. Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies.
FOUNDER AND DIRECTOR:
Omer Harpaz, M.S.M, Extensive experience in managing companies in the plastics and medical field
Amnon Rofe, M.D. - Senior Gynecologist, CEO of the Bnai Zion Medical Center, Haifa, Israel.
Amnon Weichselbaum, Ph.D. in Medical Sciences – Seasoned entrepreneur in the medical field. Founder of:
– Fertiligent –slow release insemination device
– Bacterioscan – electro-optical device for bacterial detection
Nizar Mishael,. CPA and MBA, has hands-on financial management experience at all levels: from seed investment through early and late financial rounds. Managing partner and CFO of NGT3vc early stage fund
Dr. Arie Ben Josef- Over 20 years of managerial experience in the medical device and healthcare industries
MARKETING AND SALES:
Yaron Samama M.B.A, Seasoned business development, marketing & sales manager with a 15+ year track record of bringing innovative, diverse medical devices to international markets.
Marwan H.Odeh, M.D. - Senior Gynecologist, in charge of the Obstetrics and Gynecology Ultrasound Unit at Hospital of Western Galilee, Nahariya, Israel
Javier Vico, M.D. - Senior Gynecologist, Hospital General Santa Maria del Puerto, Cadiz, Spain.
Javier Pantoja, M.D. - Senior Gynecologist, Hospital General Santa Maria del Puerto, Cadiz, Spain
The Aqueduct device combines the advantages of rods dilation and Laminaria and enables radial dilation (as with laminaria) within minutes (as with Hegar's rods).
• Easy to operate and fast dilation procedure: Provides gradual and uniform dilation to a predetermined diameter within minutes.
• Increases the accuracy and safety of the procedure: Eliminates dilation failure
• Single act of insertion through the cervix: Reduces the risk of infection, perforation, and cervical incompetence.
• Reduction of need for local or general anesthesia.